Financhill
Back

IDEXX Laboratories Quote, Financials, Valuation and Earnings

IDEXX Laboratories Price Quote

$509.27
+8.72 (+1.74%)
(Updated: September 16, 2024 at 2:55 PM ET)

IDEXX Laboratories Key Stats

Buy
56
IDEXX Laboratories (IDXX) is a Buy

Day range:
$495.60 - $508.07
52-week range:
$372.50 - $583.39
Dividend yield:
0%
P/E ratio:
49.76
P/S ratio:
11.09
P/B ratio:
26.07%

Volume:
318.9K
Avg. volume:
456.4K
1-year change:
9.22%
Market cap:
$41.2B
Revenue:
$3.7B
EPS:
$10.1

How Much Does IDEXX Laboratories Make?

Is IDEXX Laboratories Growing As A Company?

  • What Is IDEXX Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.06%
  • What Is IDEXX Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.09%

IDEXX Laboratories Stock Price Performance

What Is IDEXX Laboratories 52-Week High & Low?

IDEXX Laboratories Price To Free Cash Flow

Is It Risky To Buy IDEXX Laboratories?

  • How Much Debt Does IDEXX Laboratories Have?
    Total long term debt quarterly is $944.9M
  • How Much Cash Does IDEXX Laboratories Have?
    Cash and short term investments quarterly total is $401.6M
  • What Is IDEXX Laboratories’s Book Value Per Share?
    Book value per share is 19.16

Is IDEXX Laboratories Cash Flow Positive?

  • What Is IDXX Cash Flow From Operations?
    Cash flow from operations (TTM) is $969.2M
  • What Is IDEXX Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$499.2M
  • What Is IDEXX Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$198.1M

IDEXX Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    IDXX return on invested capital is 35.48%
  • What Is IDEXX Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 26.45%
  • What Is IDXX Return On Equity?
    ROE is a measure of profitability and is 60.19%

IDEXX Laboratories Earnings Date & Stock Price

IDEXX Laboratories Competitors

  • Who Are IDEXX Laboratories's Competitors?
    Below is a list of companies who compete with IDEXX Laboratories or are related in some way:
    • Baxter International Inc (BAX)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • ResMed Inc (RMD)

IDEXX Laboratories Dividend Yield

IDEXX Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: -8.61% 5.21%
Revenue: 6.35% 0.01%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 546.78
Upside from Last Price: 9.24%

Major Shareholders

  • How many IDXX shares are owned by institutional investors?
    113.7M IDXX shares are owned by institutional investors
  • How many IDXX shares are owned by insiders?
    946.4K IDXX shares are owned by insiders